Loading...
Current guidelines recommend delaying noncardiac surgery for at least 6 months after percutaneous coronary intervention to insert a drug-eluting stent (DES). By linking government registries, Danish investigators identified 4303 patients who underwent DES between 2005 and 2012 and who had a surgical procedure within the year. The comparison group included 20,232 surgical patients without ischemic heart disease, matched to the DES patients by age, sex, and surgical characteristics.
About 60% of patients received a first-generation DES, and 56% had an acute coronary syndrome. More DES patients than controls had comorbidities. Surgery in the DES group was more common within the first 3 months than in the next 3 quarters. Compared with surgery a…